A quantum-dot based protein module for in vivo monitoring of protease activity through fluorescence resonance energy transfer

被引:36
作者
Biswas, Payal [2 ]
Cella, Lakshmi N. [1 ,3 ]
Kang, Seung Hyun [2 ]
Mulchandani, Ashok [2 ]
Yates, Marylynn V. [4 ]
Chen, Wilfred [1 ]
机构
[1] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA
[2] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA
[3] Univ Calif Riverside, Cell Mol & Dev Biol Grad Program, Riverside, CA 92521 USA
[4] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA
基金
美国国家科学基金会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; MATRIX METALLOPROTEINASES; ELASTIN-PROTEIN; HIV-1; PROTEASE; INHIBITORS; RESISTANCE; TARGETS; PHASE; VPR;
D O I
10.1039/c1cc10648a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Here, we present a new generation of nanoscale probes for in vivo monitoring of protease activity by fluorescence resonance energy transfer (FRET). The approach is based on a genetically programmable protein module carrying a fluorescently labeled, protease-specific sequence that can self-assemble onto quantum dots. The protein module was used for real-time detection of human immunodeficiency virus type-1 protease (HIV-1 Pr) activity as well as quantitative assessment of inhibitor efficiency.
引用
收藏
页码:5259 / 5261
页数:3
相关论文
共 29 条
  • [1] Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569
  • [2] Dynamic imaging of protease activity with fluorescently quenched activity-based probes
    Blum, G
    Mullins, SR
    Keren, K
    Fonovic, M
    Jedeszko, C
    Rice, MJ
    Sloane, BF
    Bogyo, M
    [J]. NATURE CHEMICAL BIOLOGY, 2005, 1 (04) : 203 - 209
  • [3] Resistance to human immunodeficiency virus type 1 protease inhibitors
    Boden, D
    Markowitz, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2775 - 2783
  • [4] BRYD CM, 2006, DRUG DEVELOP RES, V67, P501
  • [5] Model system for high-throughput screening of novel human immunodeficiency virus protease inhibitors in Escherichia coli
    Cheng, TJ
    Brik, A
    Wong, CH
    Kan, CC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) : 2437 - 2447
  • [6] Suppression of HIV-1 protease inhibitor resistance by phosphonate-mediated solvent anchoring
    Cihlar, Tomas
    He, Gong-Xin
    Liu, Xiaohong
    Chen, James M.
    Hatada, Marcos
    Swaminathan, Swami
    McDermott, Martin J.
    Yang, Zheng-Yu
    Mulato, Andrew S.
    Chen, Xiaowu
    Leavitt, Stephanie A.
    Stray, Kirsten M.
    Lee, William A.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2006, 363 (03) : 635 - 647
  • [7] Controlling apoptosis by inhibition of caspases
    Concha, NO
    Abdel-Meguid, SS
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (06) : 713 - 726
  • [8] VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES
    CONNOR, RI
    CHEN, BK
    CHOE, S
    LANDAU, NR
    [J]. VIROLOGY, 1995, 206 (02) : 935 - 944
  • [9] Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery
    Delehanty, James B.
    Boeneman, Kelly
    Bradburne, Christopher E.
    Robertson, Kelly
    Medintz, Igor L.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (10) : 1091 - 1112
  • [10] Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides
    Gupta, B
    Levchenko, TS
    Torchilin, VP
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) : 637 - 651